Skip to content

Comparison of microneedling vs microneedling with platelet rich plasma in the treatment of male-pattern hairloss

Comparative study for the efficacy of microneedling alone and microneedling with platelet rich plasma in male-pattern hairloss - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/065133
Enrollment
40
Registered
2024-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L649- Androgenic alopecia, unspecified

Interventions

Intervention1: Microneedling with PRP: Patients in this group will receive three sessions of microneedling with PRP application at 0, 4 and 8 weeks Control Intervention1: Microneedling: Patients in t

Sponsors

Government Medical College and Hospital, Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Males above the age of 18 years diagnosed with AGA Hamilton grade 3, 4, 5 2. New cases of male pattern hair loss 3. Previously treated cases not under any treatment for past 6 months

Exclusion criteria

Exclusion criteria: 1. Malignancy or chemotherapy 2. Hematological or autoimmune disorder 3. Thrombocyte dysfunction, bleeding disorders or on anticoagulant therapy 4. Scalp area to be treated having any infection or dermatitis

Design outcomes

Primary

MeasureTime frame
To evaluate the improvement in hair growthTimepoint: The three primary efficacy measures will be the change in total and terminal hair count, scoring of the global photographs by evaluators and patient self assessment, assessed in both the groups at baseline and at 4 weekly intervals at 4, 8 and 12 weeks.

Secondary

MeasureTime frame
Adverse Effects of TreatmentTimepoint: At each follow up visits- 4, 8 & 12 weeks.

Countries

India

Contacts

Public ContactDr Jasleen Kaur

Government Medical College and Hospital, Chandigarh

jasleenksandhu21@gmail.com9646481249

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026